BIOMAT Database Logo BIOMAT Database Logo

[Effect of obzidan test on blood prolactin level in patients with toxic diffuse goiter]. 1982

M I Balabolkin, and T V Mokhort

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D005260 Female Females
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor

Related Publications

M I Balabolkin, and T V Mokhort
[Effect of merkazolyl on the level of thyrostimulating immunoglobulins of the blood in patients with diffuse toxic goiter].
January 1989, Problemy endokrinologii,
M I Balabolkin, and T V Mokhort
[Blood lipids in patients with diffuse toxic goiter and hypothyreosis].
January 1971, Problemy endokrinologii,
M I Balabolkin, and T V Mokhort
[Effect of oxygen on thyroid function in patients with diffuse toxic goiter].
October 1977, Klinicheskaia khirurgiia,
M I Balabolkin, and T V Mokhort
Effect of therapy on the serum thyroglobulin concentration in patients with toxic diffuse goiter, toxic nodular goiter and toxic adenoma.
August 1987, Journal of endocrinological investigation,
M I Balabolkin, and T V Mokhort
[Effect of reserpine on blood lipid and urine catecholamine levels in patients with diffuse toxic goiter].
July 1971, Terapevticheskii arkhiv,
M I Balabolkin, and T V Mokhort
[The effect of mercasolyl on immunologic indicators in patients with diffuse toxic goiter].
February 1989, Vrachebnoe delo,
M I Balabolkin, and T V Mokhort
[Treatment of patients with toxic diffuse goiter].
October 1983, Klinicheskaia meditsina,
M I Balabolkin, and T V Mokhort
[Thyroid-stimulating autoantibodies in the blood of patients with diffuse toxic goiter].
January 1987, Problemy endokrinologii,
M I Balabolkin, and T V Mokhort
[Capillary permeability in patients with diffuse toxic goiter].
January 1970, Problemy endokrinologii,
M I Balabolkin, and T V Mokhort
[Effect of thyrostatic therapy on various immunologic indices in patients with diffuse toxic goiter].
January 1983, Problemy endokrinologii,
Copied contents to your clipboard!